H.A.C. Pharma Acquires Global Rights to ESBRIET® from Roche

McDermott Will & Schulte has advised H.A.C. Pharma on the deal. H.A.C. Pharma, a French pharmaceutical company, has acquired the worldwide rights, excluding the United States,…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here